Shri Disha Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.40 Cr
- Paid Up Capital ₹ 2.40 Cr
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.14 Cr
- Revenue Growth 99.92%
- Profit Growth 483.94%
- Ebitda 67.16%
- Net Worth 2.28%
- Total Assets -1.29%
About Shri Disha Biotech
Shri Disha Biotech Private Limited (SDBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 April 1995 and has a history of 29 years and ten months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.40 Cr and a paid-up capital of Rs 2.40 Cr.
The company currently has active open charges totaling ₹1.14 Cr.
Brahmachari Nalmand, Ram Gopala, Bhargavi Enjeti, and One other member serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01119TG1995PTC020008
- Company No.
020008
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shri Disha Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindranath Enjeti  | Managing Director | 02-Nov-1995 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Brahmachari Nalmand | Director | 12-Mar-2022 | Current |
| Ram Gopala | Director | 12-Mar-2022 | Current |
| Bhargavi Enjeti | Director | 17-Apr-1995 | Current |
Financial Performance of Shri Disha Biotech.
Shri Disha Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 99.92% increase. The company also saw a substantial improvement in profitability, with a 483.94% increase in profit. The company's net worth moved up by a moderate rise of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Disha Biotech?
In 2021, Shri Disha Biotech had a promoter holding of 88.27% and a public holding of 11.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.14 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.64 Cr
- Agri. Business Finance Limited : 0.30 Cr
- The Vysya Bank Ltd. : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jun 2005 | State Bank Of India | ₹6.40 M | Open |
| 01 Jan 1999 | Agri. Business Finance Limited | ₹2.95 M | Open |
| 15 Dec 1997 | The Vysya Bank Ltd. | ₹2.00 M | Open |
How Many Employees Work at Shri Disha Biotech?
Shri Disha Biotech has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Disha Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Disha Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
